VI
EW icon

Vestcor Inc’s Edwards Lifesciences EW Stock Holding History

Vestcor Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$984K Sell
10,877
-1,478
-12% -$124K 0.02% 562
2026
Q1 		$989K Hold
12,355
– – 0.03% 504
2025
Q4 		$1.05M Hold
12,355
– – 0.03% 473
2025
Q3 		$961K Hold
12,355
– – 0.03% 497
2025
Q2 		$966K Buy
12,355
+1,437
+13% +$107K 0.03% 504
2025
Q1 		$791K Sell
10,918
-4,875
-31% -$349K 0.03% 509
2024
Q4 		$1.17M Buy
15,793
+4,887
+45% +$342K 0.04% 408
2024
Q3 		$720K Hold
10,906
– – 0.02% 567
2024
Q2 		$1.01M Hold
10,906
– – 0.03% 430
2024
Q1 		$1.04M Sell
10,906
-1,612
-13% -$135K 0.04% 408
2023
Q4 		$954K Sell
12,518
-122
-1% -$8.49K 0.03% 455
2023
Q3 		$876K Sell
12,640
-829
-6% -$66.6K 0.03% 453
2023
Q2 		$1.27M Sell
13,469
-3,910
-22% -$340K 0.05% 371
2023
Q1 		$1.44M Buy
17,379
+1,001
+6% +$78.7K 0.05% 357
2022
Q4 		$1.22M Buy
16,378
+1,729
+12% +$133K 0.04% 415
2022
Q3 		$1.21M Buy
14,649
+146
+1% +$14K 0.05% 425
2022
Q2 		$1.38M Buy
14,503
+4,628
+47% +$479K 0.05% 417
2022
Q1 		$1.16M Sell
9,875
-842
-8% -$94.5K 0.04% 450
2021
Q4 		$1.39M Sell
10,717
-5,786
-35% -$675K 0.05% 357
2021
Q3 		$1.87M Sell
16,503
-1,315
-7% -$150K 0.07% 296
2021
Q2 		$1.84M Sell
17,818
-1,127
-6% -$106K 0.06% 326
2021
Q1 		$1.58M Sell
18,945
-271
-1% -$22.9K 0.06% 347
2020
Q4 		$1.75M Sell
19,216
-986
-5% -$81.8K 0.07% 312
2020
Q3 		$1.61M Sell
20,202
-449
-2% -$35K 0.07% 280
2020
Q2 		$1.43M Buy
20,651
+7,256
+54% +$516K 0.07% 266
2020
Q1 		$842K Buy
13,395
+2,547
+23% +$184K 0.05% 340
2019
Q4 		$844K Buy
+10,848
New +$847K 0.04% 373

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Vestcor Inc's EW Position: Q2 2026 in Review

Vestcor Inc reduced its Edwards Lifesciences (EW) stake by 12% in Q2 2026, selling an estimated $124K and leaving 10,877 shares worth $984K. The position accounts for 0.02% of the portfolio, ranked #562.

Vestcor Inc first reported a position in EW in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.87M in Q3 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vestcor Inc held 10,877 shares of Edwards Lifesciences worth $984K as of Q2 2026.
  • Vestcor Inc sold 1,478 Edwards Lifesciences shares in Q2 2026, an estimated $124K.
  • Edwards Lifesciences made up 0.02% of Vestcor Inc's portfolio in Q2 2026, its #562 holding.
  • Vestcor Inc first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's Edwards Lifesciences position peaked at $1.87M in Q3 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.